Jorge Di Paola

Summary

Affiliation: University of Colorado Denver
Country: USA

Publications

  1. doi request reprint Thrombocytopenias due to gray platelet syndrome or THC2 mutations
    Jorge Di Paola
    Department of Pediatrics, Human Medical Genetics Program, University of Colorado, Denver, Colorado, USA
    Semin Thromb Hemost 37:690-7. 2011
  2. doi request reprint Presurgical pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in patients with von Willebrand's disease (VWD) has limited value in dosing for surgery
    J Di Paola
    University of Colorado Denver, Aurora, CO, USA
    Haemophilia 17:752-8. 2011
  3. doi request reprint Making a diagnosis of VWD
    Brian R Branchford
    Department of Pediatrics, Section of Hematology Oncology Bone Marrow Transplantation, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
    Hematology Am Soc Hematol Educ Program 2012:161-7. 2012
  4. doi request reprint New developments in the treatment of pediatric hemophilia and bleeding disorders
    Brian R Branchford
    Department of Pediatrics, Section of Hematology Oncology Bone Marrow Transplantation, Children s Hospital Colorado, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, USA
    Curr Opin Pediatr 25:23-30. 2013

Research Grants

  1. Genetic Modifiers of von Willebrand Disease
    JORGE A DIPAOLA; Fiscal Year: 2010

Collaborators

Detail Information

Publications5

  1. doi request reprint Thrombocytopenias due to gray platelet syndrome or THC2 mutations
    Jorge Di Paola
    Department of Pediatrics, Human Medical Genetics Program, University of Colorado, Denver, Colorado, USA
    Semin Thromb Hemost 37:690-7. 2011
    ..In this article, we summarize the recent discoveries in these two forms of thrombocytopenia, including the functional data that support a role for MASTL kinase in thrombopoiesis...
  2. doi request reprint Presurgical pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in patients with von Willebrand's disease (VWD) has limited value in dosing for surgery
    J Di Paola
    University of Colorado Denver, Aurora, CO, USA
    Haemophilia 17:752-8. 2011
    ....
  3. doi request reprint Making a diagnosis of VWD
    Brian R Branchford
    Department of Pediatrics, Section of Hematology Oncology Bone Marrow Transplantation, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
    Hematology Am Soc Hematol Educ Program 2012:161-7. 2012
    ..Finally, common testing pitfalls and diagnostic dilemmas are covered, including the challenge created by the overlap of borderline low VWF levels and mild bleeding...
  4. doi request reprint New developments in the treatment of pediatric hemophilia and bleeding disorders
    Brian R Branchford
    Department of Pediatrics, Section of Hematology Oncology Bone Marrow Transplantation, Children s Hospital Colorado, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, USA
    Curr Opin Pediatr 25:23-30. 2013
    ..Because of the limitations of current treatment options, novel therapies are being developed, many of which are reviewed here...

Research Grants2

  1. Genetic Modifiers of von Willebrand Disease
    JORGE A DIPAOLA; Fiscal Year: 2010
    ..Overall we believe that this project will provide new insights into the genetics of VWD and could have important implications for understanding the genetic basis of bleeding and thrombosis. ..